FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More
FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More
MedShadow ArticlesWhat To Know About Cobenfy, First New FDA-Approved Treatment For Schizophrenia in DecadesJessica DiGiacinto
MedShadow ArticlesThe FDA’s New Drug Ad Rules Are Here. Will They Actually Change Anything?Emma Yasinski
MedShadow ArticlesINVESTIGATING GENERICS: Real People Share Their Struggles With Generic ADHD MedicationsEmma Yasinski
Drug Interactions/Side EffectsSleeping Pill Use Tied to Poorer Survival for Heart Failure PatientsMedshadow Staff
MedShadow ArticlesMission Critical Update: Medication Safety Updates from the FDA DelayedEmma Yasinski
MedShadow ArticlesMedication Safety For Older Adults: Strategies To Reduce Risk And Improve CareGoldina Erowele, PharmD
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: New Liver Injury Warnings for MS Drugs and Epilepsy TreatmentKatie Rowley
